儿童的BCR/ABL阳性慢性髓性白血病:当前的治疗方法
Jenna M Menger1, Ryan S Sathianathen2, Kathleen M Sakamoto3
1Division of Pediatric Hematology/Oncology/Stem Cell Transplant, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, 10069, USA. pnu9001@nyp.org.
Current oncology reports
|February 10, 2024
概括
新的氨酸激酶抑制剂 (TKI) 显示出治疗儿科慢性髓性白血病 (CML) 的前景. 研究正在探索更短的治疗时间和向疗法,以改善CML儿童的治疗结果.
科学领域:
- 儿科血液学 瘤学 儿科血液学
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 儿童慢性髓性白血病 (CML) 通常通过终身氨酸激酶抑制剂 (TKI) 疗法进行治疗.
- 优化TKI选择和持续时间对于改善长期结果和尽量减少儿科患者的毒性至关重要.
研究的目的:
- 总结了儿科CML的最新治疗建议.
- 讨论正在进行的研究和儿科CML管理的未来方向.
主要方法:
- 关于儿科CML治疗的当前文献和临床试验数据的综述.
- 分析新兴疗法,包括新技术知识和无治疗缓解策略.
主要成果:
- 新的第一阶段数据表明,阿西米尼布 (asciminib) 是一种非ATP竞争性TKI,在儿科CML中具有安全性.
- 有证据表明,使用第二代TKI的更深层次的缓解可能允许更短的治疗疗程.
- 更有针对性的TKI可能会减少特定于儿科患者群体的副作用.
结论:
- 终身TKI治疗仍然是慢性阶段儿科CML的标准,但更短的疗程可能是可行的.
- 有针对性的技术技能可以提高儿童的安全性和有效性.
- 在移植前通过第二代TKI实现完全的血液缓解对于儿童晚期CML至关重要.
相关概念视频
Bone Marrow Sampling and Transplants
331
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
331
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K


